A uniform procedure for reimbursing the off-label use of antineoplastic drugs according to the value-for-money approach.
J Chemother
; 23(2): 67-70, 2011 Apr.
Article
in En
| MEDLINE
| ID: mdl-21571620
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Reimbursement Mechanisms
/
Off-Label Use
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Health_economic_evaluation
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Chemother
Journal subject:
ANTINEOPLASICOS
/
TERAPIA POR MEDICAMENTOS
Year:
2011
Document type:
Article
Affiliation country:
Italy